Haemonetics HAE
NYSE HAE
$101.01 -2.15 (-2.08%)
As of: Sep 10, 2026 · 3:24 PM EDT

Haemonetics (HAE) Receivables - Other (2012 - 2018)

Haemonetics (HAE) posted Receivables - Other of $5.0 million for Q1 2018, little changed on a QoQ basis from $5.0 million in Q4 2017, and up 72.41% year-over-year from $2.9 million in Q1 2017.

Analysis

Haemonetics (HAE) Receivables - Other (2012 - 2018) Analysis & Trends

Haemonetics has reported Receivables - Other for 3 years, with the latest figure at $5.0 million in Q1 2018.

  • On a quarterly basis, Receivables - Other rose 72.41% year-over-year to $5.0 million in Q1 2018; TTM through Mar 2018 was $5.0 million, a 72.41% increase from a year earlier, with the FY2018 full-year figure at $5.0 million, up 72.41% from the prior year.
  • Receivables - Other was $5.0 million for Q1 2018 at Haemonetics, roughly flat from $5.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $5.0 million in Q4 2017, with the low at $2.1 million in Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.08 Bn 174.48 Bn 7.27 Bn
2 Intuitive Surgical 127.86 Bn 122.64 Bn 1.96 Bn
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn
4 Stryker 103.82 Bn 100.34 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn
7 Alcon 32.95 Bn 31.49 Bn 1.68 Bn
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn
10 Haemonetics 4.58 Bn 4.36 Bn 202.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 5.00 Mn
Dec 30, 2017 5.00 Mn
Sep 30, 2017 2.10 Mn
Jul 1, 2017 2.90 Mn
Apr 1, 2017 2.90 Mn
Dec 29, 2012 8.20 Mn
Sep 29, 2012 100,000.00
Mar 31, 2012 3.20 Mn